Non-resectable Hepatocellular Carcinoma
Non-resectable hepatocellular carcinoma is a type of liver cancer that cannot be surgically removed. It often arises in individuals with chronic liver disease and can lead to serious health complications.
Liver Cancer: Immunotherapy and Radioactive Treatment Study
We are studying the effects of two immunotherapy drugs combined with a special treatment for liver cancer. This trial aims to see if this combination improves survival and quality of life for patients with non-resectable liver cancer.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you between 18 and 75 years old?
- Do you have a diagnosis of liver cancer (HCC)?
- Do you have any major liver problems, like severe liver disease or complications from liver disease?
- Have you had any major bleeding from your stomach or intestines in the last 4 weeks?
- Have you received any treatment for liver cancer before, like chemotherapy or targeted therapy?
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Charite Universitaetsmedizin Berlin KöR
Medizinische Klinik mit Schwerpunkt Hepatologie und Gastroenterologie
Berlin, Germany
Universitaetsklinikum Essen AöR
Clinic for Gastroenterology and Hepatology
Essen, Germany
Universitaet Leipzig
Hepatology, Medicine II
Leipzig, Germany
Sponsor: Klinikum der Universitaet Muenchen AöR
Last updated: Nov 27, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.